Literature DB >> 8642029

Repair of partial-thickness defects in articular cartilage: cell recruitment from the synovial membrane.

E B Hunziker1, L C Rosenberg.   

Abstract

Partial-thickness defects evolving in mature articular cartilage do not heal spontaneously. This type of defect was created in the articular cartilage of adult rabbits and Yucatan minipigs, and the effects of chondroitinase ABC or trypsin, fibrin clots, and mitogenic growth factors on the healing process were examined histologically at intervals ranging from one to forty-eight weeks. The effect of chondroitinase ABC or trypsin was examined initially. Articular cartilage contains macromolecules, including proteoglycans, which render the surfaces of this tissue, and of partial-thickness defects within it, antiadhesive. Chondroitinase ABC digests the glycosaminoglycan chains of cartilage proteoglycans, and trypsin degrades their core proteins. To test the hypothesis that mesenchymal cells may be prevented from adhering to and migrating over the surfaces of partial-thickness defects by proteoglycans, we removed a superficial layer of these macromolecules from the surface of the defect with use of one of these enzymes. The treatment evoked an increase in the coverage of the defect surface with mesenchymal cells; when combined with the local application of a mitogenic growth factor (basic fibroblast growth factor, transforming growth factor-beta 1, epidermal growth factor, insulin-like growth factor-1, or growth hormone), the coverage was more extensive but mesenchymal cells did not extend into and completely fill the volume of the defect. When the surface of the defect was treated with chondroitinase ABC and the cavity of the defect was filled with a fibrin clot to furnish a matrix or scaffolding for the migration of cells therein, there was migration and proliferation of cells throughout the volume of the defect but at a low population density. Mesenchymal cells remodeled the deposited fibrin matrix, which was replaced by a loose fibrous connective tissue. When defects that had been treated with chondroitinase ABC were filled with a fibrin clot containing a mitogenic growth factor, mesenchymal cells filled the entire cavity of the defect, and the density of the cells was greatly increased, particularly when transforming growth factor-beta 1 was used. Histological studies revealed a continuous layer of mesenchymal cells extending from the synovial membrane across the superficial tangential zone of normal articular cartilage into the defect, indicating that the cells that were recruited for the repair process were of synovial origin. At forty-eight weeks, the entire cavity of the defect remained filled with a fibrous connective tissue.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642029     DOI: 10.2106/00004623-199605000-00012

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  87 in total

1.  A novel method to examine the phenotype of chondrocytes.

Authors:  R Kuijer; D A Surtel; A J Van Der Linden; S K Bulstra; R C Passier
Journal:  J Mater Sci Mater Med       Date:  1998-12       Impact factor: 3.896

Review 2.  The stem cell niche should be a key issue for cell therapy in regenerative medicine.

Authors:  José Becerra; Leonor Santos-Ruiz; José A Andrades; Manuel Marí-Beffa
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

3.  Intraarticular injection of heparin-binding insulin-like growth factor 1 sustains delivery of insulin-like growth factor 1 to cartilage through binding to chondroitin sulfate.

Authors:  Rachel E Miller; Alan J Grodzinsky; Kiersten Cummings; Anna H K Plaas; Ada A Cole; Richard T Lee; Parth Patwari
Journal:  Arthritis Rheum       Date:  2010-12

4.  Chondrogenic progenitor cells respond to cartilage injury.

Authors:  Dongrim Seol; Daniel J McCabe; Hyeonghun Choe; Hongjun Zheng; Yin Yu; Keewoong Jang; Morgan W Walter; Abigail D Lehman; Lei Ding; Joseph A Buckwalter; James A Martin
Journal:  Arthritis Rheum       Date:  2012-11

5.  Enzyme Pretreatment plus Locally Delivered HB-IGF-1 Stimulate Integrative Cartilage Repair In Vitro.

Authors:  Paul H Liebesny; Keri Mroszczyk; Hannah Zlotnick; Han-Hwa Hung; Eliot Frank; Bodo Kurz; Gustavo Zanotto; David Frisbie; Alan J Grodzinsky
Journal:  Tissue Eng Part A       Date:  2019-09-03       Impact factor: 3.845

6.  Surgical suturing of articular cartilage induces osteoarthritis-like changes.

Authors:  E B Hunziker; A Stähli
Journal:  Osteoarthritis Cartilage       Date:  2008-03-04       Impact factor: 6.576

Review 7.  Mesenchymal Stem/Progenitor Cells Derived from Articular Cartilage, Synovial Membrane and Synovial Fluid for Cartilage Regeneration: Current Status and Future Perspectives.

Authors:  Yi-Zhou Huang; Hui-Qi Xie; Antonietta Silini; Ornella Parolini; Yi Zhang; Li Deng; Yong-Can Huang
Journal:  Stem Cell Rev Rep       Date:  2017-10       Impact factor: 5.739

8.  The Effect of Growth Hormone on Chondral Defect Repair.

Authors:  Natalie R Danna; Bryan G Beutel; Austin J Ramme; Thorsten Kirsch; Oran D Kennedy; Eric Strauss
Journal:  Cartilage       Date:  2016-12-12       Impact factor: 4.634

Review 9.  Emerging potential of gene silencing approaches targeting anti-chondrogenic factors for cell-based cartilage repair.

Authors:  Andrea Lolli; Letizia Penolazzi; Roberto Narcisi; Gerjo J V M van Osch; Roberta Piva
Journal:  Cell Mol Life Sci       Date:  2017-04-22       Impact factor: 9.261

10.  Cartilage constructs engineered from chondrocytes overexpressing IGF-I improve the repair of osteochondral defects in a rabbit model.

Authors:  H Madry; G Kaul; D Zurakowski; G Vunjak-Novakovic; M Cucchiarini
Journal:  Eur Cell Mater       Date:  2013-04-16       Impact factor: 3.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.